Analysts have been eager to weigh in on the Healthcare sector with new ratings on Takeda Pharmaceutical Company (TAK – Research Report) and Axcella Health (AXLA – Research Report). Takeda Pharmaceutical Company (TAK) J.P. Morgan analyst James Gordon maintained a Hold rating on Takeda Pharmaceutical Company yesterday and set a price target of $12.80. The company's shares closed last Friday at $12.97, close to its 52-week low of $12.75. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-takeda-pharmaceutical-company-tak-and-axcella-health-axla?utm_source=advfn.com&utm_medium=referral
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From May 2023 to Jun 2023 Click Here for more Axcella Health Charts.
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Jun 2022 to Jun 2023 Click Here for more Axcella Health Charts.